Supriya Lifescience Limited — Investor Relations & Filings
Supriya Lifescience Limited is a research-driven manufacturer of Active Pharmaceutical Ingredients (APIs) with a focus on diverse therapeutic segments. The company specializes in the production of antihistamines, anti-allergics, vitamins, anesthetics, and anti-asthmatics. Its core product portfolio includes Chlorpheniramine Maleate, Ketamine Hydrochloride, and Salbutamol Sulphate, maintaining a significant global market share in these niche categories. Operating with a strong emphasis on backward integration, the firm ensures supply chain reliability and cost efficiency. The manufacturing infrastructure is compliant with international regulatory standards, including approvals from the USFDA, EDQM, and PMDA. Supriya Lifescience serves a broad international clientele across more than 100 countries, catering to both regulated and semi-regulated markets through its advanced R&D capabilities and commitment to quality excellence.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| General Updates | 2026-04-22 | English | |
| Shareholders meeting | 2026-04-11 | English | |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-10 | English | |
| Trading Window | 2026-03-25 | English | |
| Change in Director(s) | 2026-03-24 | English | |
| Reply to Clarification- Financial results | 2026-03-13 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 42182500 | General Updates | 2026-04-22 | English | ||
| 42195800 | Shareholders meeting | 2026-04-11 | English | ||
| 42206530 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-10 | English | ||
| 42181490 | Trading Window | 2026-03-25 | English | ||
| 42193625 | Change in Director(s) | 2026-03-24 | English | ||
| 42196646 | Reply to Clarification- Financial results | 2026-03-13 | English | ||
| 42168202 | Copy of Newspaper Publication | 2026-03-11 | English | ||
| 42179477 | Shareholders meeting | 2026-03-10 | English | ||
| 42189781 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-02-17 | English | ||
| 42236162 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-02-10 | English | ||
| 42241780 | Copy of Newspaper Publication | 2026-02-10 | English | ||
| 42241946 | Press Release | 2026-02-10 | English | ||
| 42248209 | Investor Presentation | 2026-02-09 | English | ||
| 42248562 | Change in Director(s) | 2026-02-09 | English | ||
| 42248932 | Outcome of Board Meeting | 2026-02-09 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
89bio, Inc.
Clinical-stage biopharma developing therapies for liver and…
|
ETNB | US | Manufacturing |
|
Aardvark Therapeutics, Inc.
Clinical-stage biopharma developing therapeutics for hunger…
|
AARD | US | Manufacturing |
|
Aarey Drugs & Pharmaceuticals Ltd
Manufactures APIs and chemical intermediates for global pha…
|
AAREYDRUGS | IN | Manufacturing |
|
Aarti Drugs Limited
Produces APIs, pharma intermediates, and specialty chemical…
|
AARTIDRUGS | IN | Manufacturing |
|
Aarti Pharmalabs Limited
Manufacturer of APIs, intermediates, and xanthines with glo…
|
AARTIPHARM | IN | Manufacturing |
|
AAYUSH WELLNESS LIMITED
Develops and markets herbal formulations, supplements, and …
|
539528 | IN | Manufacturing |
|
Ab&B Bio-Tech CO., LTD. JS
Biopharmaceutical company engaged in the R&D and commercial…
|
2627 | HK | Manufacturing |
|
Abbisko Cayman Limited
Clinical-stage biopharma focused on discovering and develop…
|
2256 | KY | Manufacturing |
|
Abbott India Ltd.
Provides pharmaceutical solutions in gastroenterology, card…
|
ABBOTINDIA | IN | Manufacturing |
|
ABBOTT LABORATORIES
Global healthcare company in medical devices, diagnostics, …
|
ABT | US | Manufacturing |
Supriya Lifescience Limited via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/59375/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=59375 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=59375 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=59375 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 59375}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Supriya Lifescience Limited (id: 59375)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.